US Patent 7153829 Kallikrein-inhibitor therapies
Patent 7153829 was granted and assigned to Dyax on December, 2006 by the United States Patent and Trademark Office.
All edits
Edits on 11 Sep, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 6 Sep, 2023
Golden AI
Edits made to:
Infobox (+6 properties)
Infobox
Patent Inventor Names
Anthony Williams0
Arthur C. Ley0
Luigi Bergamaschini0
Maria Grazia De Simoni0
Robert C. Ladner0
Shirish Hirani0
Edits on 31 Aug, 2023
Golden AI
Edits made to:
Article (+199 characters)
Article
Patent abstract
Methods are described for preventing or reducing ischemia, e.g., cerebral ischemia, and/or reperfusion injury, e.g., reperfusion injury associated with cerebral ischemia, in a patient.
Edits on 24 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07153829 Kallikrein-inhibitor therapies US Patent 7153829 Kallikrein-inhibitor therapies
Infobox
Patent Number
071538290
Patent Number
71538290
Edits on 18 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 24 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
0
Patent Jurisdiction
Patent Number
071538290
Date of Patent
December 26, 2006
0Patent Application Number
109539020
Date Filed
September 27, 2004
0Official Website
Patent Primary Examiner
Edits on 8 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 19 Nov, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07153829 Kallikrein-inhibitor therapies
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07153829
Date of patent
December 26, 2006
Patent application number
10953902
Date Filed
September 27, 2004
Patent primary examiner
Find more entities like US Patent 7153829 Kallikrein-inhibitor therapies
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
